AH Bio Fund I, L.P. 13D and 13G filings for CAMP4 Therapeutics Corporation:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-11-14 6:23 pm Unchanged | 2025-09-30 | 13G | CAMP4 Therapeutics Corporation CAMP | AH Bio Fund I, L.P. | 2,125,339 4.500% | 0 (Unchanged) | Filing |
| 2024-10-22 4:19 pm Purchase | 2024-10-15 | 13G | CAMP4 Therapeutics Corporation CAMP | AH Bio Fund I, L.P. | 2,125,339 10.900% | 2,125,339 (New Position) | Filing |